KV Pharmaceutical Company faces class action lawsuit

KV Pharmaceutical Company is likely to face a class action lawsuit from the purchasers of its common stock during the period between February 15, 2008 and November 12, 2008. Dyer & Berens LLP today announced the class action lawsuit in the United States District Court for the Eastern District of Missouri.

Full article »

Lawsuit against drug maker KV Pharmaceutical and subsidiary

An investor class action lawsuit was filed against the KV Pharmaceutical Company, the the parent company of Ethex Corp. The lawsuit was filed on December 2, 2008, in the United States District Court for the Eastern District of Missouri on behalf of investors who purchased Class A Common Stock (NYSE: KV-A), Class B Common Stock (NYSE: KV-B) and 7% cumulative convertible Preferred Stock (Symbol: KVPHP) between February 15, 2008 and November 12, 2008.

Full article »


Protected by Comment Guard Pro